Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands.

导出 OA

翻译打印收藏纠错

第一作者： Felix,Johnson

第一单位： Department of Otorhinolaryngology, University Clinic of Innsbruck, 6020 Innsbruck, Austria.

作者： Felix,Johnson ^[1] ; Benedikt,Hofauer ^[1] ; Markus,Wirth ^[2] ; Barbara,Wollenberg ^[2] ; Fabian,Stögbauer ^[3] ; Susan,Notohamiprodjo ^[4] ; Bernhard,Haller ^[5] ; Robin,Reschke ^[6] ; Andreas,Knopf ^[7] ; Ulrich,Strassen ^[2]

作者单位： Department of Otorhinolaryngology, University Clinic of Innsbruck, 6020 Innsbruck, Austria. ^[1] Department of Otorhinolaryngology, Technical University of Munich (TUM), 85354 Freising, Germany. ^[2] Institute of General and Surgical Pathology, TUM School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany. ^[3] Department of Nuclear Medicine, Technical University of Munich (TUM), 85354 Freising, Germany. ^[4] Institut für KI und Informatik in der Medizin, 81675 München, Germany. ^[5] Department of Dermatology and Venereology, Universitätsklinikum Hamburg-Eppendorf, Fleur Hiege Center for Skin Cancer Research, 20246 Hamburg, Germany. ^[6] Department of Otorhinolaryngology, Head and Neck Surgery, Albert-Ludwigs-Universität Freiburg, 79085 Freiburg, Germany. ^[7]

关键词 SSTR2 carcinoma ex pleomorphic adenoma immunohistochemistry pleomorphic adenoma radionuclide therapy salivary gland tumors somatostatin receptor theranostic tumor marker warthin tumor

DOI 10.3390/cancers15153917

PMID 37568733

发布时间 2023-08-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交